AbbVie Shares Slide, Bristol Myers Shares Rise After Schizophrenia Study Setback — Update
AbbVie shares, which hit a 52-week high in late October after the drugmaker posted quarterly earnings that topped Wall Street's expectations and raised its dividend by nearly 6%, were recently down ...
AbbVie Down Over 13%, on Pace for Largest Percent Decrease Since June 2019 — Data Talk
--On pace for largest percent decrease since June 25, 2019, when it fell 16.25% --Currently down four consecutive days; down 14.17% over this period ...
AbbVie's closely watched schizophrenia drug fails two studies, shares slide
AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...
AbbVie declines after missing main goal in schizophrenia treatment trials
AbbVie (ABBV) shares dropped 11% premarket as late-stage trials for schizophrenia drug emraclidine did not meet primary ...
AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia
EMPOWER-1 and EMPOWER-2 Phase 2 clinical trials did not meet their primary endpoint Emraclidine was well-tolerated with an adverse event profile consistent with ...
Yahoo Finance7h
Splash Car Wash Opens Its 65th Site
MILFORD, Conn., Nov. 11, 2024 /PRNewswire/ -- Splash Car Wash, headquartered in Milford, Connecticut, today announced the opening of its 65 th location, an express wash in Johnson City, New York. The ...